T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Louisiana-Pacific
LPX
$5.15B
| $46.4M | ﹤0.01% |
769,686
+700,798
| +1,017% | +$44.8M |
|
1052
Bloomin' Brands
BLMN
$924M
| $46.3M | ﹤0.01% |
1,704,125
-1,139,311
| -40% | -$32.2M |
|
|
CHCT
1053
Community Healthcare Trust
CHCT
$430M
| $45.9M | ﹤0.01% |
968,066
+112,448
| +13% | +$5.5M |
|
1054
Highwoods Properties
HIW
$3.51B
| $45.9M | ﹤0.01% |
1,017,094
+186,670
| +22% | +$8.4M |
|
1055
Expeditors International
EXPD
$24B
| $45.8M | ﹤0.01% |
361,809
-7,390
| -2% | -$872K |
|
1056
ABM Industries
ABM
$2.84B
| $45.8M | ﹤0.01% |
1,031,847
+413,241
| +67% | +$20.7M |
|
1057
Ameriprise Financial
AMP
$49.9B
| $45.7M | ﹤0.01% |
183,548
-3,657
| -2% | -$922K |
|
1058
CBRE Group
CBRE
$42.7B
| $45.6M | ﹤0.01% |
532,147
-6,192
| -1% | -$529K |
|
1059
Knowles
KN
$3.23B
| $45.5M | ﹤0.01% |
2,303,395
-554,606
| -19% | -$11.3M |
|
1060
Uber
UBER
$155B
| $45.4M | ﹤0.01% |
905,630
+47,389
| +6% | +$2.48M |
|
|
PFPT
1061
DELISTED
Proofpoint, Inc.
PFPT
| $45.3M | ﹤0.01% |
260,905
-6,363,019
| -96% | -$1.03B |
|
1062
Perdoceo Education
PRDO
$1.96B
| $45.1M | ﹤0.01% |
3,677,759
+365,194
| +11% | +$4.46M |
|
|
INVX
1063
Innovex International
INVX
$2.15B
| $44.9M | ﹤0.01% |
1,326,614
-51,474
| -4% | -$1.73M |
|
|
BSKYU
1064
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
| $44.8M | ﹤0.01% |
+4,486,156
| New | +$44.9M |
|
1065
Curtiss-Wright
CW
$25.4B
| $44.7M | ﹤0.01% |
376,023
-3,184
| -0.8% | -$398K |
|
|
ABMD
1066
DELISTED
Abiomed Inc
ABMD
| $44.5M | ﹤0.01% |
142,666
+2,476
| +2% | +$760K |
|
1067
Inspire Medical Systems
INSP
$1.68B
| $44.5M | ﹤0.01% |
230,316
-163
| -0.1% | -$32.3K |
|
1068
W.P. Carey
WPC
$16.1B
| $44.5M | ﹤0.01% |
608,399
-371
| -0.1% | -$27.2K |
|
1069
Protagonist Therapeutics
PTGX
$9.8B
| $44.3M | ﹤0.01% |
986,254
+72,664
| +8% | +$2.4M |
|
1070
Maximus
MMS
$2.94B
| $44.1M | ﹤0.01% |
500,771
-30,249
| -6% | -$2.77M |
|
|
CNTA
1071
DELISTED
Centessa Pharmaceuticals
CNTA
| $43.9M | ﹤0.01% |
+2,011,073
| New | +$47.3M |
|
1072
Goodyear
GT
$1.78B
| $43.8M | ﹤0.01% |
2,555,725
+671,899
| +36% | +$12.4M |
|
|
AGC
1073
DELISTED
Altimeter Growth Corp
AGC
| $43.8M | ﹤0.01% |
+3,744,300
| New | +$45.8M |
|
1074
Abercrombie & Fitch
ANF
$4.99B
| $43.8M | ﹤0.01% |
942,458
+335,539
| +55% | +$13.5M |
|
1075
Howard Hughes
HHH
$4.04B
| $43.7M | ﹤0.01% |
470,539
+176,550
| +60% | +$17.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.